Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#2906 Change of Lactate Transporter (MCT4) Expression in Pancreatic Microadenomas and Stages of Pancreatic Neuroendocrine Tumors

Introduction: Metabolic changes are observed in early and late stages of Pancreatic Neuroendocrine Tumors (PanNET) in mouse models. In human PanNET, RNA-expression analysis showed changes in glucose metabolism in more aggressive PanNET.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Bräutigam K

Authors: Straub J, Bräutigam K, Di Domenico A, Galván J, Maire R,

Keywords: metabolism, microadenoma, immunohistochemistry, pancreas, tumor, mct4, relapse,

#460 Treatment of Unresectable Metastatic GEP NETs: Data From a Prospective Observational Unicentric Study

Introduction: In 2010 Everolimus, Sunitinib and Capecitabine plus Temozolamide confirmed efficacy in NETs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Fonseca P, Galvan J, Gutierrez E, Álvarez C, Pérez Q,

Keywords: gep-net, SSA, Everolimus, Sunitinib, Temozolomide, Capecitabine,

#253 Description and Treatment of GEP NETs in a Spanish Hospital During 10 Years

Introduction: In our area the GEP NET incidence is similar to that of gastric and exocrine pancreatic cancers consequently being important to know their characteristics and the most convenient therapeutic approach.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vieitez J, Galvan J, Crespo G, Frunza M,

Keywords: gastroenteropancreatic neuroendocrine tumors, histology, chemotherapy, streptozocin-based regimen,

#241 One-year Response to Everolimus in a Case of Advanced Pancreatic NET

Introduction: A stage IV pancreatic NET (30 mitoses/10 PF and Ki-67 index=40%) with liver and peritoneal metastases was diagnosed in a 35-year-old woman in June 2008. Characteristics: ECOG2 and CgA 1701 ng/ml.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vietez J, Galvan J, Crespo G, Astudillo A,

Keywords: pancreatic neuroendocrine tumor, Everolimus, Somatostatin Analogues, chemotherapy,

#191 Immunohistochemical Analysis of Epithelial-Mesenchymal Transition Markers in Neuroendocrine Tumors of the Lung

Introduction: The increased motility and invasiveness of cancer cells in the first phase of metastasis are reminiscent of epithelial–mesenchymal transition (EMT) during embryonic development.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Galván J, González M, Fonseca P, Folgueras M, Astudillo A,

Keywords: EMT, snail, slug, twist, foxC2, cadherin, pulmonary neuroendocrine tumors ,